Molecular Cytogenetics Global Market to Reach $3.5 Billion by 2030: Rising Adoption of Array Based CGH to Spur Overall Demand
11 Apr 2023
DUBLIN, April 10, 2023 /PRNewswire/ -- The "Molecular Cytogenetics: Global Strategic Business Report" report has been added to
ResearchAndMarkets.com's offering.
The global market for Molecular Cytogenetics estimated at US$1.8 Billion in the year 2022, is projected to reach a revised size of US$3.5 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2022-2030.
Consumables, one of the segments analyzed in the report, is projected to record a 8.8% CAGR and reach US$2 Billion by the end of the analysis period.
Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 7.7% CAGR for the next 8-year period.
The U.S. Market is Estimated at $794.6 Million, While China is Forecast to Grow at 10% CAGR
The Molecular Cytogenetics market in the U.S. is estimated at US$794.6 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$231.4 Million by the year 2030 trailing a CAGR of 10% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 7.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$313.8 Million by the year 2030.
Select Competitors (Total 44 Featured) -
Applied Spectral Imaging
Cytognomix, Inc.
What`s New for 2023?
Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year
Key Attributes:
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Impact of COVID-19 and a Looming Global Recession
COVID-19 Leaves the World in Shambles & Industries and Markets Upended: World Economic Growth Projections (Real GDP, Annual % Change) for 2019E to 2022F
Challenges and Opportunities for Clinical Diagnostics amid the Pandemic
French Research Team Develops CoronaFISH
Immuno RNA Fluorescence ISH for Visualization of COVID-19 Causing SARS-CoV-2
Molecular Cytogenetics Technologies: An Introductory Prelude
Future Prospects Remain Favorable for Cytogenetics Technologies
Uptrend in Life Sciences R&D and Healthcare Spending Creates Fertile Environment
World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
Northbound Trajectory in Med Tech Sector to Generate Parallel Opportunities
Developed Regions: Key Revenue Contributors
Developed Regions Account for Lion's Share of World Molecular Cytogenetics Technologies Market: Percentage Breakdown of Revenues for Developed and Developing Regions (2020E & 2027P)
Fast Paced Growth Projected in Developing Regions
Global Market for Molecular Cytogenetics Technologies - Geographic Regions Ranked by % CAGR (Revenues) for 2020-2027: China, Asia-Pacific, Latin America, USA, Middle East, Africa, Canada, Europe, and Japan
Competitive Scenario
Recent Market Activity
Molecular Cytogenetics - Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Critical Importance of Molecular Biology in Laboratory Processes: Cornerstone for Present & Future Growth
Advanced Molecular Biology Techniques Broaden the Scope of Cytogenetics Technologies
Comparative Genome Hybridization (CGH): Largest & Fastest Growing Market Segment
Rising Adoption of Array Based CGH to Spur Overall Demand
Array-based Technologies Continue to Cannibalize Sales from FISH Technology: Percentage (%) Share of Array-Based Solutions in World Cytogenetics Technologies Market (2018 & 2022)
aCGH Simplifies Diagnosis of Chromosomal Anomalies
Clinical Pathological Testing: A Growing Vertical for aCGH
Impact of Rising Emphasis on R&D on Microarray Technology
Leveraging Established Use Case, FISH Technology Continues to Find Favor
Next Generation Sequencing Seeks Role in Cytogenetics Processes
Molecular Cytogenetics Greatly Benefit Cancer Prognosis
Breakdown of Total Number of Cancer Cases by Region: 2020
Breakdown of Total Number of Cancer Cases by Type: 2020
Cancer Care Made Easier with Highly-Multiplexed FISH
Diverse Applications of FISH Technology in Oncology
Growing Demand for Targeted Therapies in Cancer Treatment Presents Lucrative Opportunities
Increasing Significance of Cytogenetic Analysis in Genetic Disease Diagnosis
Uptrend in Genetic Disease Testing Augments Prospects
List of Genetic Disorders by Event, Genetic Manifestation and Prevalence
Top Ten Genetic Diseases Worldwide
Proven Efficacy in Nucleic Acid Diagnostics Favors Market Growth
Expanding Role of Molecular Cytogenetics in Personalized Medicine
Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
World Personalized Medicine Market by Region/Country (2021): Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific and Rest of World
Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population
Companion Diagnostics Lead the Way to Personalized Medicine
Digitalization, Automation and AI Trends Set to Shape Future Growth
Lab Automation Speeds Up
World Laboratory Automation Market in US$ Billion for Years 2018, 2020, 2022, 2024 & 2026
Laboratory 4.0 Set to Transform Molecular Cytogenetics Landscape
Laboratory Information Systems Gain Traction
Artificial Intelligence : The Future of LIS
Biotech Research Spending Patterns Steer Momentum
Technology Advancements & Improvements Bolster Growth
Ageing Demographics to Drive Demand
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Life Expectancy at Age 60 and 80 Years: (2010-2015), (2020-2025) & (2045-2050)
Technology Overview
A Preface to Cytogenetics
Basic Terms and Definitions in Molecular Biology
An Overview of Select Chromosomal Anomalies
Molecular Cytogenetics
Insight into Molecular Cytogenetics Techniques
Fluorescence in situ Hybridization (FISH)
Comparative Genomic Hybridization (CGH)
Advent of Microarray Technology
Microarrays in Comparative Genomic Hybridization
Principle Underlying aCGH
Low Resolution and High Resolution aCGH
A Review of Molecular Biology Techniques in Cytogenetics
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/ppnlpw
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.